Current ethical and legal issues in health-related direct-to-consumer genetic testing

Research output: Contribution to journal › Review › Research › peer-review

Standard

Current ethical and legal issues in health-related direct-to-consumer genetic testing. / Niemiec, Emilia; Kalokairinou, Louiza; Howard, Heidi Carmen.

In: Personalized Medicine, Vol. 14, No. 5, 09.2017, p. 433-445.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Niemiec, E, Kalokairinou, L & Howard, HC 2017, 'Current ethical and legal issues in health-related direct-to-consumer genetic testing', Personalized Medicine, vol. 14, no. 5, pp. 433-445. https://doi.org/10.2217/pme-2017-0029

APA

Niemiec, E., Kalokairinou, L., & Howard, H. C. (2017). Current ethical and legal issues in health-related direct-to-consumer genetic testing. Personalized Medicine, 14(5), 433-445. https://doi.org/10.2217/pme-2017-0029

Vancouver

Niemiec E, Kalokairinou L, Howard HC. Current ethical and legal issues in health-related direct-to-consumer genetic testing. Personalized Medicine. 2017 Sep;14(5):433-445. https://doi.org/10.2217/pme-2017-0029

Author

Niemiec, Emilia ; Kalokairinou, Louiza ; Howard, Heidi Carmen. / Current ethical and legal issues in health-related direct-to-consumer genetic testing. In: Personalized Medicine. 2017 ; Vol. 14, No. 5. pp. 433-445.

Bibtex

@article{809ce517118d46a291686acf016606ab,

title = "Current ethical and legal issues in health-related direct-to-consumer genetic testing",

abstract = "A variety of health-related genetic testing is currently advertized directly to consumers. This article provides a timely overview of direct-to-consumer genetic testing (DTC GT) and salient ethical issues, as well as an analysis of the impact of the recently adopted regulation on in vitro diagnostic medical devices on DTC GT. DTC GT companies currently employ new testing approaches, report on a wide spectrum of conditions and target new groups of consumers. Such activities raise ethical issues including the questionable analytic and clinical validity of tests, the adequacy of informed consent, potentially misleading advertizing, testing in children, research uses and commercialization of genomic data. The recently adopted regulation on in vitro diagnostic medical devices may limit the offers of predisposition DTC GT in the EU market.",

keywords = "consumer genetics, consumer genomics, direct-to-consumer genetic testing, genetic counseling, genetic testing, informed consent, IVD Regulation",

author = "Emilia Niemiec and Louiza Kalokairinou and Howard, {Heidi Carmen}",

note = "Publisher Copyright: {\textcopyright} 2017 Future Medicine Ltd.",

year = "2017",

month = sep,

doi = "10.2217/pme-2017-0029",

language = "English",

volume = "14",

pages = "433--445",

journal = "Personalized Medicine",

issn = "1741-0541",

publisher = "Future Medicine Ltd.",

number = "5",

}

RIS

TY - JOUR

T1 - Current ethical and legal issues in health-related direct-to-consumer genetic testing

AU - Niemiec, Emilia

AU - Kalokairinou, Louiza

AU - Howard, Heidi Carmen

PY - 2017/9

Y1 - 2017/9

N2 - A variety of health-related genetic testing is currently advertized directly to consumers. This article provides a timely overview of direct-to-consumer genetic testing (DTC GT) and salient ethical issues, as well as an analysis of the impact of the recently adopted regulation on in vitro diagnostic medical devices on DTC GT. DTC GT companies currently employ new testing approaches, report on a wide spectrum of conditions and target new groups of consumers. Such activities raise ethical issues including the questionable analytic and clinical validity of tests, the adequacy of informed consent, potentially misleading advertizing, testing in children, research uses and commercialization of genomic data. The recently adopted regulation on in vitro diagnostic medical devices may limit the offers of predisposition DTC GT in the EU market.

AB - A variety of health-related genetic testing is currently advertized directly to consumers. This article provides a timely overview of direct-to-consumer genetic testing (DTC GT) and salient ethical issues, as well as an analysis of the impact of the recently adopted regulation on in vitro diagnostic medical devices on DTC GT. DTC GT companies currently employ new testing approaches, report on a wide spectrum of conditions and target new groups of consumers. Such activities raise ethical issues including the questionable analytic and clinical validity of tests, the adequacy of informed consent, potentially misleading advertizing, testing in children, research uses and commercialization of genomic data. The recently adopted regulation on in vitro diagnostic medical devices may limit the offers of predisposition DTC GT in the EU market.

KW - consumer genetics

KW - consumer genomics

KW - direct-to-consumer genetic testing

KW - genetic counseling

KW - genetic testing

KW - informed consent

KW - IVD Regulation

UR - http://www.scopus.com/inward/record.url?scp=85029917412&partnerID=8YFLogxK

U2 - 10.2217/pme-2017-0029

DO - 10.2217/pme-2017-0029

M3 - Review

C2 - 29754566

AN - SCOPUS:85029917412

VL - 14

SP - 433

EP - 445

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 5

ER -

ID: 369542712

Det Juridiske Fakultet